<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20231201060234N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2024-06-22</date_registration>
      <primary_sponsor>CMH Peshawar</primary_sponsor>
      <public_title>Medical versus surgical treatment for chronic anal fissure</public_title>
      <acronym></acronym>
      <scientific_title>Comparison between treatment efficacy of glyceryl trinitrate and lateral sphincterotomy for chronic anal fissure</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-01-01</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>240</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/74506</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Simple randomization was done using individual type. The method used was chits marked X and Y using the lottery method. The sealed chits were selected once the patient entered the recovery room. The resident surgeon deputed for patient selection of the chits was unaware of the study protocol and allocation concealment was done. Only the consultant in the operating room was aware of the protocol, Blinding description: Both the final assessor and data analyzer were unaware of the study protocol.</study_design>
      <phase>1-2</phase>
      <hc_freetext>Chronic anal fissure.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group 1: Surgical lateral sphincterotomy group. Patients in Group S received the surgical procedure by a consultant surgeon and part of the internal anal sphincter was dissected to relieve the fissure induced spasm and were followed up till 8 weeks at 4,6 and 8 week duration for the primary and secondary outcomes mentioned. Intervention 2: Intervention group 2: Glyceryl trinitrate group.Patients received 0.2% ointment of glyceryl trinitrate and directed by a resident surgeon on its correct application in the perianal area using 1-2 ml twice a day for a total of 8 weeks and followed up similarly at 4,6 and 8 weeks duration.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
All the data including patients records (excluding patient identification IDs), excel sheets, analysis proformas and SPSS output sheets will be made available to all researchers for academic purposes when requested through online repository, link of which will be shared once approval given from the primary author and the institute in which the study was carried out

When:
Will be available indefinitely pending approval by the primary author and institute

To whom:
For academic purposes only

Conditions:
The manuscript along with SPSS data sets and output sheets will be shared once published by the journal 
Will be shared via email

Where to obtain:
Will be sent both my email and will be available online and link would be provided as well on Google Drive

How to obtain:
Email to the institute and the primary author

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Rashid Ali</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>D7</address>
        <city>Peshawar</city>
        <country1>Pakistan</country1>
        <zip>25000</zip>
        <telephone>+92 81 2850639</telephone>
        <email>Rashid_zahidbaloch@hotmail.com</email>
        <affiliation>CMH Peshawar</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Rashid Ali</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>D7</address>
        <city>Peshawar</city>
        <country1>Pakistan</country1>
        <zip>25000</zip>
        <telephone>+92 81 2850639</telephone>
        <email>Rashid_zahidbaloch@hotmail.com</email>
        <affiliation>CMH Peshawar</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Pakistan</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Patients more than 18 years of age
With a chronic non-healing anal fissure more than 8 weeks duration
Presenting to the surgical out-patient department for treatment.</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Pregnancy
Recurrent anal fissures
Major cardiac or respiratory disease
Unwilling to be included in the study</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>K60.1</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Chronic anal fissure</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Surgery</i_code>
      <i_code>Treatment - Drugs</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group 1: Surgical lateral sphincterotomy group. Patients in Group S received the surgical procedure by a consultant surgeon and part of the internal anal sphincter was dissected to relieve the fissure induced spasm and were followed up till 8 weeks at 4,6 and 8 week duration for the primary and secondary outcomes mentioned.</i_keyword>
      <i_keyword>Intervention group 2: Glyceryl trinitrate group.Patients received 0.2% ointment of glyceryl trinitrate and directed by a resident surgeon on its correct application in the perianal area using 1-2 ml twice a day for a total of 8 weeks and followed up similarly at 4,6 and 8 weeks duration.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Mean time to complete fissure healing. Timepoint: Assessed weekly after intervention till endpoint of healing or failure of healing after 8 weeks. Method of measurement: Subjective assessment by a surgical consultant.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Median pain scores. Timepoint: Weekly will 8 weeks. Method of measurement: Visual analog pain score by a surgical consultant.</sec_outcome>
      <sec_outcome>Episodes of bleeding post-procedure. Timepoint: Weekly for 8 weeks after procedure. Method of measurement: Assessment subjectively by.a consultant surgical specialist.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>CMH Peshawar</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2023-02-07</approval_date>
        <contact_name>Ethical Review board CMH Peshawar</contact_name>
        <contact_address>Mall road; Peshawar Peshawar KPK Pakistan</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
